Welcome to Gulf Coast ATTC

Regional Home

Trainings & Events

Products & Resources

From this ATTC
From Local Groups
Regional Links

Special Topics

Academic Programming

The UT Addiction Research Institute

Archived Products

Contact Us

Staff Directory

The Gulf Coast Addiction Technology Transfer Center (Gulf Coast ATTC) works through multiple consortia of educational institutions and other agencies to promote incorporation of research into addictions curricula and provides technical assistance and consultation for state agencies and community organizations in Texas, Louisiana, and New Mexico to facilitate workforce development and the implementation of evidence-based practices. For more information on related addiction studies and projects, visit the Addiction Research Institute (ARI) of the Center for Social Work Research at The University of Texas at Austin.

Objectives

• Develop and maintain State and regional consortia across and among:
  • State Agencies
  • Educational Institutions
  • Providers and Consumers.
• Maintain active linkages with research resources.
• Convene research-to-practice conferences, research seminars, and training sessions focusing on implementation of evidence-based practices.
• Conduct state training needs assessment and help implement research-based curricula for pre-service students and practicing addictions counselors. A key focus of this effort is to utilize culturally competent course content and methods.
• Facilitate adoption of improvements in professional standards in the addictions field.
• Provide technical assistance to providers, state agencies, and planning groups.
• Maintain a center of excellence in drug abuse epidemiology and provide consultation on monitoring drug trends and service needs.

The Center for Excellence in Epidemiology offers epidemiologists and planners access to online manuals, surveys, state and local needs assessments, and other data sources on substance abuse. This site will enable providers to take advantage of the latest research on new and emerging problem drugs in assessing treatment needs.